Unverified50% confidenceFactExact time
GLP-1 receptor agonists mimic the action of the body's natural glucagon-like peptide-1 (GLP-1), promoting insulin release, inhibiting glucagon secretion, delaying gastric emptying, and acting on the central nervous system to produce a sense of fullness.
1
Sources
50%
Confidence
Long-term
Relevance
10/20/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedA company has developed a viral vector carrying the GLP-1 gene that uses the insulin gene promoter of beta cells to enable patients to simultaneously secrete GLP-1 when secreting insulin, and it has entered the clinical trial stage.75% similarUnverifiedA therapy that ablates the duodenal lining to reset the diseased intestinal lining can reduce HbA1c by more than one percentage point, and there is preliminary evidence suggesting it may prevent weight regain after discontinuation of GLP-1.70% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1077914API
curl https://kongchang.com/api/v1/knowledge/claims/1077914MCP
get_claim(id=1077914)